Literature DB >> 24171527

Treatment for high-risk smoldering myeloma.

Sigurdur Y Kristinsson, Erik Holmberg, Cecilie Blimark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24171527     DOI： 10.1056/NEJMc1310911

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

Review 1.  Smoldering multiple myeloma.

Authors:  S Vincent Rajkumar; Ola Landgren; María-Victoria Mateos
Journal:  Blood       Date:  2015-04-02       Impact factor: 22.113

2.  Timing of treatment of smoldering myeloma: early treatment.

Authors:  María-Victoria Mateos; Verónica González-Calle
Journal:  Blood Adv       Date:  2018-11-13

3.  Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma.

Authors:  V González-Calle; J Dávila; F Escalante; A G de Coca; C Aguilera; R López; A Bárez; J M Alonso; R Hernández; J M Hernández; P de la Fuente; N Puig; E M Ocio; N C Gutiérrez; R García-Sanz; M V Mateos
Journal:  Leukemia       Date:  2016-05-02       Impact factor: 11.528

4.  Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma.

Authors:  Sham Mailankody; Dickran Kazandjian; Neha Korde; Mark Roschewski; Elisabet Manasanch; Manisha Bhutani; Nishant Tageja; Mary Kwok; Yong Zhang; Adriana Zingone; Laurence Lamy; Rene Costello; Candis Morrison; Malin Hultcrantz; Austin Christofferson; Megan Washington; Martin Boateng; Seth M Steinberg; Maryalice Stetler-Stevenson; William D Figg; Elli Papaemmanuil; Wyndham H Wilson; Jonathan J Keats; Ola Landgren
Journal:  Blood Adv       Date:  2017-09-29

Review 5.  Shall we treat smoldering multiple myeloma in the near future?

Authors:  Ola Landgren
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

6.  How I treat smoldering multiple myeloma.

Authors:  Irene M Ghobrial; Ola Landgren
Journal:  Blood       Date:  2014-10-08       Impact factor: 22.113

Review 7.  Dilemmas in treating smoldering multiple myeloma.

Authors:  Inhye E Ahn; Sham Mailankody; Neha Korde; Ola Landgren
Journal:  J Clin Oncol       Date:  2014-11-24       Impact factor: 44.544

Review 8.  Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).

Authors:  Ashish Patel; Chia Yin Goh; Matthew Ho; Maria Moscvin; Li Zhang; Giada Bianchi
Journal:  Leukemia       Date:  2020-10-12       Impact factor: 11.528

9.  Development of an Algorithm to Distinguish Smoldering Versus Symptomatic Multiple Myeloma in Claims-Based Data Sets.

Authors:  Mark A Fiala; James Dukeman; Sascha A Tuchman; Matt Keller; Ravi Vij; Tanya M Wildes
Journal:  JCO Clin Cancer Inform       Date:  2017-12-21

Review 10.  Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma: A Review.

Authors:  Francesco Maura; Niccolò Bolli; Even H Rustad; Malin Hultcrantz; Nikhil Munshi; Ola Landgren
Journal:  JAMA Oncol       Date:  2020-03-01       Impact factor: 31.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.